Global siRNA Drug Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global siRNA Drug market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China siRNA Drug market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An siRNA drug, short for small interfering RNA drug, is a type of therapeutic agent that utilizes synthetic RNA molecules to selectively silence the expression of specific disease-causing genes. These drugs are designed to target and inhibit the production of messenger RNA (mRNA) molecules that encode proteins involved in various diseases, ranging from viral infections to genetic disorders and cancer. By harnessing the natural mechanism of RNA interference, siRNA drugs offer a potent and highly specific approach to gene regulation, with the potential to treat a wide range of medical conditions. They are typically administered via various delivery methods, including nanoparticles, to ensure efficient uptake by target cells and achieve therapeutic effects. Ongoing research aims to optimize the design and delivery of siRNA drugs, addressing challenges such as off-target effects and immune response, to enhance their safety and efficacy in clinical applications.
The major global manufacturers of siRNA Drug include Genzyme, Alnylam, Dicerna, Quark Pharmaceuticals, Arrowhead, Exicure, Miragen Therapeutics, Silence, Sylentis, Avidity Biosciences, Dicerna, BioNTech, Moderna Therapeutics, The WhiteOak Group, Inc., etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of siRNA Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global siRNA Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the siRNA Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of siRNA Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of siRNA Drug Include:
Genzyme
Alnylam
Dicerna
Quark Pharmaceuticals
Arrowhead
Exicure
Miragen Therapeutics
Silence
Sylentis
Avidity Biosciences
Dicerna
BioNTech
Moderna Therapeutics
The WhiteOak Group, Inc.
siRNA Drug Product Segment Include:
Givlaari
Patisiran
Givosiran
siRNA Drug Product Application Include:
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global siRNA Drug Industry PESTEL Analysis
Chapter 3: Global siRNA Drug Industry Porter's Five Forces Analysis
Chapter 4: Global siRNA Drug Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global siRNA Drug Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global siRNA Drug Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, siRNA Drug Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global siRNA Drug market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China siRNA Drug market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An siRNA drug, short for small interfering RNA drug, is a type of therapeutic agent that utilizes synthetic RNA molecules to selectively silence the expression of specific disease-causing genes. These drugs are designed to target and inhibit the production of messenger RNA (mRNA) molecules that encode proteins involved in various diseases, ranging from viral infections to genetic disorders and cancer. By harnessing the natural mechanism of RNA interference, siRNA drugs offer a potent and highly specific approach to gene regulation, with the potential to treat a wide range of medical conditions. They are typically administered via various delivery methods, including nanoparticles, to ensure efficient uptake by target cells and achieve therapeutic effects. Ongoing research aims to optimize the design and delivery of siRNA drugs, addressing challenges such as off-target effects and immune response, to enhance their safety and efficacy in clinical applications.
The major global manufacturers of siRNA Drug include Genzyme, Alnylam, Dicerna, Quark Pharmaceuticals, Arrowhead, Exicure, Miragen Therapeutics, Silence, Sylentis, Avidity Biosciences, Dicerna, BioNTech, Moderna Therapeutics, The WhiteOak Group, Inc., etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of siRNA Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global siRNA Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the siRNA Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of siRNA Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of siRNA Drug Include:
Genzyme
Alnylam
Dicerna
Quark Pharmaceuticals
Arrowhead
Exicure
Miragen Therapeutics
Silence
Sylentis
Avidity Biosciences
Dicerna
BioNTech
Moderna Therapeutics
The WhiteOak Group, Inc.
siRNA Drug Product Segment Include:
Givlaari
Patisiran
Givosiran
siRNA Drug Product Application Include:
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global siRNA Drug Industry PESTEL Analysis
Chapter 3: Global siRNA Drug Industry Porter's Five Forces Analysis
Chapter 4: Global siRNA Drug Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global siRNA Drug Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global siRNA Drug Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, siRNA Drug Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 siRNA Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 siRNA Drug Product by Type
- 1.2.1 Givlaari
- 1.2.2 Patisiran
- 1.2.3 Givosiran
- 1.3 siRNA Drug Product by Application
- 1.3.1 Single Gene Rare Disease
- 1.3.2 Protein Deposition Disease
- 1.3.3 Chronic Liver Disease
- 1.3.4 Others
- 1.4 Global siRNA Drug Market Revenue and Sales Analysis
- 1.4.1 Global siRNA Drug Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global siRNA Drug Sales Market Size Analysis (2020-2032)
- 1.4.3 Global siRNA Drug Market Sales Price Trend Analysis (2020-2032)
- 1.5 siRNA Drug Market Development Status and Trends
- 1.5.1 siRNA Drug Industry Development Status Analysis
- 1.5.2 siRNA Drug Industry Development Trends Analysis
- 2 siRNA Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 siRNA Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global siRNA Drug Market Analysis by Country
- 4.1 Global siRNA Drug Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global siRNA Drug Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global siRNA Drug Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global siRNA Drug Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global siRNA Drug Sales and Market Share by Country (2020-2025)
- 4.2.2 Global siRNA Drug Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa siRNA Drug Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global siRNA Drug Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global siRNA Drug Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global siRNA Drug Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global siRNA Drug Average Sales Price by Manufacturers (2021-2025)
- 5.2 siRNA Drug Competitive Landscape Analysis and Market Dynamic
- 5.2.1 siRNA Drug Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 siRNA Drug Market Analysis by Type
- 6.1 Global siRNA Drug Market Revenue Analysis by Type
- 6.1.1 Global siRNA Drug Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global siRNA Drug Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global siRNA Drug Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global siRNA Drug Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Genzyme
- 7.1.1 Genzyme Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Genzyme siRNA Drug Product Portfolio
- 7.1.3 Genzyme siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Alnylam
- 7.2.1 Alnylam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Alnylam siRNA Drug Product Portfolio
- 7.2.3 Alnylam siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Dicerna
- 7.3.1 Dicerna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Dicerna siRNA Drug Product Portfolio
- 7.3.3 Dicerna siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Quark Pharmaceuticals
- 7.4.1 Quark Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Quark Pharmaceuticals siRNA Drug Product Portfolio
- 7.4.3 Quark Pharmaceuticals siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Arrowhead
- 7.5.1 Arrowhead Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Arrowhead siRNA Drug Product Portfolio
- 7.5.3 Arrowhead siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Exicure
- 7.6.1 Exicure Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Exicure siRNA Drug Product Portfolio
- 7.6.3 Exicure siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Miragen Therapeutics
- 7.7.1 Miragen Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Miragen Therapeutics siRNA Drug Product Portfolio
- 7.7.3 Miragen Therapeutics siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Silence
- 7.8.1 Silence Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Silence siRNA Drug Product Portfolio
- 7.8.3 Silence siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Sylentis
- 7.9.1 Sylentis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Sylentis siRNA Drug Product Portfolio
- 7.9.3 Sylentis siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Avidity Biosciences
- 7.10.1 Avidity Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Avidity Biosciences siRNA Drug Product Portfolio
- 7.10.3 Avidity Biosciences siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Dicerna
- 7.11.1 Dicerna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Dicerna siRNA Drug Product Portfolio
- 7.11.3 Dicerna siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 BioNTech
- 7.12.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 BioNTech siRNA Drug Product Portfolio
- 7.12.3 BioNTech siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.13 Moderna Therapeutics
- 7.13.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Moderna Therapeutics siRNA Drug Product Portfolio
- 7.13.3 Moderna Therapeutics siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.14 The WhiteOak Group, Inc.
- 7.14.1 The WhiteOak Group, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 The WhiteOak Group, Inc. siRNA Drug Product Portfolio
- 7.14.3 The WhiteOak Group, Inc. siRNA Drug Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 siRNA Drug Industry Chain Analysis
- 8.2 siRNA Drug Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 siRNA Drug Product Downstream Application Analysis
- 8.3.1 Global siRNA Drug Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global siRNA Drug Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global siRNA Drug Sales and Forecast Analysis by Application (2020-2032)
- 8.4 siRNA Drug Typical Downstream Customers
- 8.5 siRNA Drug Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
